Seegene propose une approche globale de dépistage des infections de l'appareil génital dans le cadre de la Global Million Clinical Study (GMCS)

Data ReadoutpositiveSTAgora™Positive

AI Analysis

Summary

Seegene's STAgora study of approximately 60,000 samples demonstrated that STI pathogens were detected in 82% of HPV-positive cases, supporting the value of a comprehensive genital infection screening approach.

Clinical Trial Data

Primary Endpoint

Met

Patients

60,000

Outcome Details

STAgora study of ~60,000 test results over 42 months showed STI pathogens detected in 82% of HPV-positive cases, supporting comprehensive screening approach

Importance:5/10

Sentiment:

0.65

STI screeningHPV detectionDiagnostic studyGlobal Million Clinical StudyInfectious disease

Related Companies

$GBCYD

Read the original article

Published by PR Newswire Pharma on August 10, 2026 7:00 AM

Read Original